Analysis of V2 Antibody Responses Induced in Vaccinees in the ALVAC/AIDSVAX HIV-1 Vaccine Efficacy Trial
Abstract
The RV144 clinical trial of a prime/boost immunizing regimen using recombinant canary pox (ALVAC-HIV) and two gp120 proteins (AIDSVAX B and E) was previously shown to have a 31.2% efficacy rate. Plasma specimens from vaccine and placebo recipients were used in an extensive set of assays to identify correlates of HIV-1 infection risk. Of six primary variables that were studied, only one displayed a significant inverse correlation with risk of infection: the antibody (Ab) response to a fusion protein containing the V1 and V2 regions of gp120 (gp70-V1V2). This finding prompted a thorough examination of the results generated with the complete panel of 13 assays measuring various V2 Abs in the stored plasma used in the initial pilot studies and those used in the subsequent case-control study. The studies revealed that the ALVACHIV/AIDSVAX vaccine induced V2-specific Abs that cross-react with multiple HIV-1 subgroups and recognize both conformational and linear epitopes. The conformational epitope was present on gp70-V1V2, while the predominant linear V2 epitope mapped to residues 165–178, immediately N-terminal to the putative a4b7 binding motif in the mid-loop region of V2. Odds ratios (ORs) were calculated to compare the risk of infection with data from 12 V2 assays, and inmore »
- Authors:
-
more »
- Veterans Affairs Medical Center, New York, NY (United States); New York University (NYU), NY (United States)
- Fred Hutchinson Cancer Research Center, Seattle, WA (United States)
- New York University (NYU), NY (United States)
- United States Army Material Command--Armed Forces Research Institute of Medical Sciences, Bangkok (Thailand)
- Duke University, Durham, NC (United States)
- Walter Reed Army Institute of Research, Silver Spring, MD (United States)
- University of California, Santa Cruz, CA (United States)
- Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
- National Institutes of Health (NIH), Bethesda, MD (United States)
- University of Medicine and Dentistry of New Jersey, Newark, NJ (United States)
- Ministry of Public Health, Nonthaburi (Thailand)
- Publication Date:
- Research Org.:
- Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
- Sponsoring Org.:
- USDOE Office of Science (SC), Biological and Environmental Research (BER); National Institutes of Health (NIH); Department of Veterans Affairs; Bill & Melinda Gates Foundation; U.S. Army Medical Research and Material Command (USAMRMC); National Institutes of Allergy and Infectious Diseases; U.S. Department of Defense (DOD)
- OSTI Identifier:
- 1627576
- Grant/Contract Number:
- AC52-06NA25396; HL59725; AI084119; Y1-AI-2642-12; W81XWH-07-2-0067; AI067854; UM1AI-068618
- Resource Type:
- Accepted Manuscript
- Journal Name:
- PLoS ONE
- Additional Journal Information:
- Journal Volume: 8; Journal Issue: 1; Journal ID: ISSN 1932-6203
- Publisher:
- Public Library of Science
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 59 BASIC BIOLOGICAL SCIENCES; HIV vaccines; antigens; HIV-1; medical risk factors; enzyme-linked immunoassays; vaccine development; pilot studies; case-control studies
Citation Formats
Zolla-Pazner, Susan, deCamp, Allan C., Cardozo, Timothy, Karasavvas, Nicos, Gottardo, Raphael, Williams, Constance, Morris, Daryl E., Tomaras, Georgia, Rao, Mangala, Billings, Erik, Berman, Phillip, Shen, Xiaoying, Andrews, Charla, O'Connell, Robert J., Ngauy, Viseth, Nitayaphan, Sorachai, de Souza, Mark, Korber, Bette, Koup, Richard, Bailer, Robert T., Mascola, John R., Pinter, Abraham, Montefiori, David, Haynes, Barton F., Robb, Merlin L., Rerks-Ngarm, Supachai, Michael, Nelson L., Gilbert, Peter B., and Kim, Jerome H. Analysis of V2 Antibody Responses Induced in Vaccinees in the ALVAC/AIDSVAX HIV-1 Vaccine Efficacy Trial. United States: N. p., 2013.
Web. doi:10.1371/journal.pone.0053629.
Zolla-Pazner, Susan, deCamp, Allan C., Cardozo, Timothy, Karasavvas, Nicos, Gottardo, Raphael, Williams, Constance, Morris, Daryl E., Tomaras, Georgia, Rao, Mangala, Billings, Erik, Berman, Phillip, Shen, Xiaoying, Andrews, Charla, O'Connell, Robert J., Ngauy, Viseth, Nitayaphan, Sorachai, de Souza, Mark, Korber, Bette, Koup, Richard, Bailer, Robert T., Mascola, John R., Pinter, Abraham, Montefiori, David, Haynes, Barton F., Robb, Merlin L., Rerks-Ngarm, Supachai, Michael, Nelson L., Gilbert, Peter B., & Kim, Jerome H. Analysis of V2 Antibody Responses Induced in Vaccinees in the ALVAC/AIDSVAX HIV-1 Vaccine Efficacy Trial. United States. https://doi.org/10.1371/journal.pone.0053629
Zolla-Pazner, Susan, deCamp, Allan C., Cardozo, Timothy, Karasavvas, Nicos, Gottardo, Raphael, Williams, Constance, Morris, Daryl E., Tomaras, Georgia, Rao, Mangala, Billings, Erik, Berman, Phillip, Shen, Xiaoying, Andrews, Charla, O'Connell, Robert J., Ngauy, Viseth, Nitayaphan, Sorachai, de Souza, Mark, Korber, Bette, Koup, Richard, Bailer, Robert T., Mascola, John R., Pinter, Abraham, Montefiori, David, Haynes, Barton F., Robb, Merlin L., Rerks-Ngarm, Supachai, Michael, Nelson L., Gilbert, Peter B., and Kim, Jerome H. Thu .
"Analysis of V2 Antibody Responses Induced in Vaccinees in the ALVAC/AIDSVAX HIV-1 Vaccine Efficacy Trial". United States. https://doi.org/10.1371/journal.pone.0053629. https://www.osti.gov/servlets/purl/1627576.
@article{osti_1627576,
title = {Analysis of V2 Antibody Responses Induced in Vaccinees in the ALVAC/AIDSVAX HIV-1 Vaccine Efficacy Trial},
author = {Zolla-Pazner, Susan and deCamp, Allan C. and Cardozo, Timothy and Karasavvas, Nicos and Gottardo, Raphael and Williams, Constance and Morris, Daryl E. and Tomaras, Georgia and Rao, Mangala and Billings, Erik and Berman, Phillip and Shen, Xiaoying and Andrews, Charla and O'Connell, Robert J. and Ngauy, Viseth and Nitayaphan, Sorachai and de Souza, Mark and Korber, Bette and Koup, Richard and Bailer, Robert T. and Mascola, John R. and Pinter, Abraham and Montefiori, David and Haynes, Barton F. and Robb, Merlin L. and Rerks-Ngarm, Supachai and Michael, Nelson L. and Gilbert, Peter B. and Kim, Jerome H.},
abstractNote = {The RV144 clinical trial of a prime/boost immunizing regimen using recombinant canary pox (ALVAC-HIV) and two gp120 proteins (AIDSVAX B and E) was previously shown to have a 31.2% efficacy rate. Plasma specimens from vaccine and placebo recipients were used in an extensive set of assays to identify correlates of HIV-1 infection risk. Of six primary variables that were studied, only one displayed a significant inverse correlation with risk of infection: the antibody (Ab) response to a fusion protein containing the V1 and V2 regions of gp120 (gp70-V1V2). This finding prompted a thorough examination of the results generated with the complete panel of 13 assays measuring various V2 Abs in the stored plasma used in the initial pilot studies and those used in the subsequent case-control study. The studies revealed that the ALVACHIV/AIDSVAX vaccine induced V2-specific Abs that cross-react with multiple HIV-1 subgroups and recognize both conformational and linear epitopes. The conformational epitope was present on gp70-V1V2, while the predominant linear V2 epitope mapped to residues 165–178, immediately N-terminal to the putative a4b7 binding motif in the mid-loop region of V2. Odds ratios (ORs) were calculated to compare the risk of infection with data from 12 V2 assays, and in 11 of these, the ORs were #1, reaching statistical significance for two of the variables: Ab responses to gp70-V1V2 and to overlapping V2 linear peptides. It remains to be determined whether anti-V2 Ab responses were directly responsible for the reduced infection rate in RV144 and whether anti-V2 Abs will prove to be important with other candidate HIV vaccines that show efficacy, however, the results support continued dissection of Ab responses to the V2 region which may illuminate mechanisms of protection from HIV-1 infection and may facilitate the development of an effective HIV-1 vaccine.},
doi = {10.1371/journal.pone.0053629},
journal = {PLoS ONE},
number = 1,
volume = 8,
place = {United States},
year = {Thu Jan 17 00:00:00 EST 2013},
month = {Thu Jan 17 00:00:00 EST 2013}
}
Works referenced in this record:
Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia
text, January 2008
- F., Haynes, B.; T., Lucas, J.; D., Tomaras, G.
- The University of North Carolina at Chapel Hill University Libraries
Analysis of a Clonal Lineage of HIV-1 Envelope V2/V3 Conformational Epitope-Specific Broadly Neutralizing Antibodies and Their Inferred Unmutated Common Ancestors
journal, July 2011
- Bonsignori, M.; Hwang, K. -K.; Chen, X.
- Journal of Virology, Vol. 85, Issue 19
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
journal, November 2011
- McLellan, Jason S.; Pancera, Marie; Carrico, Chris
- Nature, Vol. 480, Issue 7377
Presentation of native epitopes in the V1/V2 and V3 regions of human immunodeficiency virus type 1 gp120 by fusion glycoproteins containing isolated gp120 domains.
journal, January 1994
- Kayman, S. C.; Wu, Z.; Revesz, K.
- Journal of Virology, Vol. 68, Issue 1
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
journal, April 2012
- Haynes, Barton F.; Gilbert, Peter B.; McElrath, M. Juliana
- New England Journal of Medicine, Vol. 366, Issue 14
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
journal, June 1998
- Kwong, Peter D.; Wyatt, Richard; Robinson, James
- Nature, Vol. 393, Issue 6686
CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5
journal, November 1996
- Trkola, Alexandra; Dragic, Tatjana; Arthos, James
- Nature, Vol. 384, Issue 6605
Identification of a New Quaternary Neutralizing Epitope on Human Immunodeficiency Virus Type 1 Virus Particles
journal, April 2005
- Gorny, Miroslaw K.; Stamatatos, Leonidas; Volsky, Barbara
- Journal of Virology, Vol. 79, Issue 8
The Genotype of Early-Transmitting HIV gp120s Promotes α4β7 –Reactivity, Revealing α4β7+/CD4+ T cells As Key Targets in Mucosal Transmission
journal, February 2011
- Nawaz, Fatima; Cicala, Claudia; Van Ryk, Donald
- PLoS Pathogens, Vol. 7, Issue 2
Anti-V3 Monoclonal Antibodies Display Broad Neutralizing Activities against Multiple HIV-1 Subtypes
journal, April 2010
- Hioe, Catarina E.; Wrin, Terri; Seaman, Michael S.
- PLoS ONE, Vol. 5, Issue 4
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
journal, December 2009
- Rerks-Ngarm, Supachai; Pitisuttithum, Punnee; Nitayaphan, Sorachai
- New England Journal of Medicine, Vol. 361, Issue 23
Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants
journal, December 2006
- Fischer, Will; Perkins, Simon; Theiler, James
- Nature Medicine, Vol. 13, Issue 1, p. 100-106
Structure–function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design
journal, July 2010
- Zolla-Pazner, Susan; Cardozo, Timothy
- Nature Reviews Immunology, Vol. 10, Issue 7
HIV-1 envelope protein binds to and signals through integrin α4β7, the gut mucosal homing receptor for peripheral T cells
journal, February 2008
- Arthos, James; Cicala, Claudia; Martinelli, Elena
- Nature Immunology, Vol. 9, Issue 3
Correlation between Immunologic Responses to a Recombinant Glycoprotein 120 Vaccine and Incidence of HIV‐1 Infection in a Phase 3 HIV‐1 Preventive Vaccine Trial
journal, March 2005
- Gilbert, Peter B.; Peterson, Michael L.; Follmann, Dean
- The Journal of Infectious Diseases, Vol. 191, Issue 5
Crystal Structure of Human Antibody 2909 Reveals Conserved Features of Quaternary Structure-Specific Antibodies That Potently Neutralize HIV-1
journal, December 2010
- Changela, A.; Wu, X.; Yang, Y.
- Journal of Virology, Vol. 85, Issue 6
Transmitted/Founder and Chronic Subtype C HIV-1 Use CD4 and CCR5 Receptors with Equal Efficiency and Are Not Inhibited by Blocking the Integrin α4β7
journal, May 2012
- Parrish, Nicholas F.; Wilen, Craig B.; Banks, Lauren B.
- PLoS Pathogens, Vol. 8, Issue 5
Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia
journal, October 2008
- Tomaras, G. D.; Yates, N. L.; Liu, P.
- Journal of Virology, Vol. 82, Issue 24, p. 12449-12463
A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
journal, October 2011
- Pejchal, R.; Doores, K. J.; Walker, L. M.
- Science, Vol. 334, Issue 6059
Monoclonal Antibodies to the V2 Domain of MN-rgp120: Fine Mapping of Epitopes and Inhibition of α4β7 Binding
journal, June 2012
- Nakamura, Gerald R.; Fonseca, Dora P. A. J.; O'Rourke, Sara M.
- PLoS ONE, Vol. 7, Issue 6
Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1.
journal, January 1994
- Gorny, M. K.; Moore, J. P.; Conley, A. J.
- Journal of Virology, Vol. 68, Issue 12
Autoreactivity in Human IgG+ Memory B Cells
journal, February 2007
- Tiller, Thomas; Tsuiji, Makoto; Yurasov, Sergey
- Immunity, Vol. 26, Issue 2
Immunotypes of a Quaternary Site of HIV-1 Vulnerability and Their Recognition by Antibodies
journal, February 2011
- Wu, X.; Changela, A.; O'Dell, S.
- Journal of Virology, Vol. 85, Issue 9
Regularization Paths for Generalized Linear Models via Coordinate Descent
journal, January 2010
- Friedman, Jerome; Hastie, Trevor; Tibshirani, Robert
- Journal of Statistical Software, Vol. 33, Issue 1
Circulating Proteomic Signature of Early Death in Heart Failure Patients with Reduced Ejection Fraction
journal, January 2019
- Cuvelliez, Marie; Vandewalle, Vincent; Brunin, Maxime
- SSRN Electronic Journal
Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials
journal, May 2012
- Montefiori, D. C.; Karnasuta, C.; Huang, Y.
- Journal of Infectious Diseases, Vol. 206, Issue 3
The Thai Phase III HIV Type 1 Vaccine Trial (RV144) Regimen Induces Antibodies That Target Conserved Regions Within the V2 Loop of gp120
journal, November 2012
- Karasavvas, Nicos; Billings, Erik; Rao, Mangala
- AIDS Research and Human Retroviruses, Vol. 28, Issue 11
Complete Nucleotide Sequences of Functional Clones of the AIDS Virus
journal, January 1987
- Ratner, Lee; Fisher, Amanda; Jagodzinski, Linda L.
- AIDS Research and Human Retroviruses, Vol. 3, Issue 1
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
journal, June 1998
- Kwong, Peter D.; Wyatt, Richard; Robinson, James
- Nature, Vol. 393, Issue 6686
Immunoreactivity of Intact Virions of Human Immunodeficiency Virus Type 1 (HIV-1) Reveals the Existence of Fewer HIV-1 Immunotypes than Genotypes
journal, November 2000
- Nyambi, Phillipe N.; Nádas, Arthur; Mbah, Henry A.
- Journal of Virology, Vol. 74, Issue 22
Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor.
journal, January 1997
- Hill, C. M.; Deng, H.; Unutmaz, D.
- Journal of virology, Vol. 71, Issue 9
Broad neutralization coverage of HIV by multiple highly potent antibodies
journal, September 2011
- Walker, Laura M.; Huber, Michael; Doores, Katie J.
- Nature, Vol. 477, Issue 7365
Phase I/II Study of a Candidate Vaccine Designed Against the B and E Subtypes of HIV-1
journal, January 2004
- Pitisuttithum, Punnee; Berman, Phillip W.; Phonrat, Benjaluck
- JAIDS Journal of Acquired Immune Deficiency Syndromes, Vol. 37, Issue 1
The V1/V2 Domain of gp120 Is a Global Regulator of the Sensitivity of Primary Human Immunodeficiency Virus Type 1 Isolates to Neutralization by Antibodies Commonly Induced upon Infection
journal, April 2004
- Pinter, A.; Honnen, W. J.; He, Y.
- Journal of Virology, Vol. 78, Issue 10
Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia
text, January 2008
- F., Keele, Brandon; B., Hicks, Charles; T., Lucas, Judith
- The University of North Carolina at Chapel Hill University Libraries
Complete Nucleotide Sequences of Functional Clones of the AIDS Virus
journal, January 1987
- Ratner, Lee; Fisher, Amanda; Jagodzinski, Linda L.
- AIDS Research and Human Retroviruses, Vol. 3, Issue 1
Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2
journal, September 2012
- Rolland, Morgane; Edlefsen, Paul T.; Larsen, Brendan B.
- Nature, Vol. 490, Issue 7420
Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding.
journal, January 1993
- Thali, M.; Moore, J. P.; Furman, C.
- Journal of Virology, Vol. 67, Issue 7
Functional and immunochemical cross-reactivity of V2-specific monoclonal antibodies from HIV-1-infected individuals
journal, June 2012
- Gorny, Miroslaw K.; Pan, Ruimin; Williams, Constance
- Virology, Vol. 427, Issue 2
Antibodies That Are Cross-Reactive for Human Immunodeficiency Virus Type 1 Clade A and Clade B V3 Domains Are Common in Patient Sera from Cameroon, but Their Neutralization Activity Is Usually Restricted by Epitope Masking
journal, January 2005
- Krachmarov, Chavdar; Pinter, Abraham; Honnen, William J.
- Journal of Virology, Vol. 79, Issue 2
The Thai Phase III HIV Type 1 Vaccine Trial (RV144) Regimen Induces Antibodies That Target Conserved Regions Within the V2 Loop of gp120
journal, November 2012
- Karasavvas, Nicos; Billings, Erik; Rao, Mangala
- AIDS Research and Human Retroviruses, Vol. 28, Issue 11
Transmitted/Founder and Chronic Subtype C HIV-1 Use CD4 and CCR5 Receptors with Equal Efficiency and Are Not Inhibited by Blocking the Integrin α4β7
journal, May 2012
- Parrish, Nicholas F.; Wilen, Craig B.; Banks, Lauren B.
- PLoS Pathogens, Vol. 8, Issue 5
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
journal, September 2009
- Walker, L. M.; Phogat, S. K.; Chan-Hui, P. -Y.
- Science, Vol. 326, Issue 5950
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
journal, November 2011
- McLellan, Jason S.; Pancera, Marie; Carrico, Chris
- Nature, Vol. 480, Issue 7377
A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
journal, October 2011
- Pejchal, R.; Doores, K. J.; Walker, L. M.
- Science, Vol. 334, Issue 6059
Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants
journal, December 2006
- Fischer, Will; Perkins, Simon; Theiler, James
- Nature Medicine, Vol. 13, Issue 1, p. 100-106
Solid vaccine protection against SIV in rhesus monkeys provides proof-of-concept for further evaluation of a novel HIV vaccine approach in humans
journal, May 2012
- Esparza, José
- Expert Review of Vaccines, Vol. 11, Issue 5
Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials
journal, May 2012
- Montefiori, D. C.; Karnasuta, C.; Huang, Y.
- Journal of Infectious Diseases, Vol. 206, Issue 3
Potent neutralization of primary HIV-1 isolates by antibodies directed against epitopes present in the V1/V2 domain of HIV-1 gp120
journal, November 1998
- Pinter, A.
- Vaccine, Vol. 16, Issue 19
The Genotype of Early-Transmitting HIV gp120s Promotes α4β7 –Reactivity, Revealing α4β7+/CD4+ T cells As Key Targets in Mucosal Transmission
journal, February 2011
- Nawaz, Fatima; Cicala, Claudia; Van Ryk, Donald
- PLoS Pathogens, Vol. 7, Issue 2
A Conserved HIV gp120 Glycoprotein Structure Involved in Chemokine Receptor Binding
journal, June 1998
- Rizzuto, C. D.
- Science, Vol. 280, Issue 5371
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
journal, September 2009
- Walker, L. M.; Phogat, S. K.; Chan-Hui, P. -Y.
- Science, Vol. 326, Issue 5950
Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2
journal, September 2012
- Rolland, Morgane; Edlefsen, Paul T.; Larsen, Brendan B.
- Nature, Vol. 490, Issue 7420
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys
journal, January 2012
- Barouch, Dan H.; Liu, Jinyan; Li, Hualin
- Nature, Vol. 482, Issue 7383
Monoclonal Antibodies to the V2 Domain of MN-rgp120: Fine Mapping of Epitopes and Inhibition of α4β7 Binding
journal, June 2012
- Nakamura, Gerald R.; Fonseca, Dora P. A. J.; O'Rourke, Sara M.
- PLoS ONE, Vol. 7, Issue 6
Autoreactivity in Human IgG+ Memory B Cells
journal, February 2007
- Tiller, Thomas; Tsuiji, Makoto; Yurasov, Sergey
- Immunity, Vol. 26, Issue 2
Functional and immunochemical cross-reactivity of V2-specific monoclonal antibodies from HIV-1-infected individuals
journal, June 2012
- Gorny, Miroslaw K.; Pan, Ruimin; Williams, Constance
- Virology, Vol. 427, Issue 2
Structural Analysis of Human and Macaque mAbs 2909 and 2.5B: Implications for the Configuration of the Quaternary Neutralizing Epitope of HIV-1 gp120
journal, May 2011
- Spurrier, Brett; Sampson, Jared M.; Totrov, Maxim
- Structure, Vol. 19, Issue 5
Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp120.
journal, January 1993
- Gorny, M. K.; Xu, J. Y.; Karwowska, S.
- The Journal of Immunology, Vol. 150, Issue 2
Works referencing / citing this record:
An Enhanced Synthetic Multiclade DNA Prime Induces Improved Cross-Clade-Reactive Functional Antibodies when Combined with an Adjuvanted Protein Boost in Nonhuman Primates
journal, June 2015
- Wise, Megan C.; Hutnick, Natalie A.; Pollara, Justin
- Journal of Virology, Vol. 89, Issue 18
Analysis of HLA A*02 Association with Vaccine Efficacy in the RV144 HIV-1 Vaccine Trial
journal, May 2014
- Gartland, A. J.; Li, S.; McNevin, J.
- Journal of Virology, Vol. 88, Issue 15
HIV-1 vaccination by needle-free oral injection induces strong mucosal immunity and protects against SHIV challenge
journal, February 2019
- Jones, Andrew T.; Shen, Xiaoying; Walter, Korey L.
- Nature Communications, Vol. 10, Issue 1
Complex immune correlates of protection in HIV-1 vaccine efficacy trials
journal, January 2017
- Tomaras, Georgia D.; Plotkin, Stanley A.
- Immunological Reviews, Vol. 275, Issue 1
Vaccine-Induced IgG Antibodies to V1V2 Regions of Multiple HIV-1 Subtypes Correlate with Decreased Risk of HIV-1 Infection
journal, February 2014
- Zolla-Pazner, Susan; deCamp, Allan; Gilbert, Peter B.
- PLoS ONE, Vol. 9, Issue 2
IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens
journal, November 2015
- Karasavvas, Nicos; Karnasuta, Chitraporn; Savadsuk, Hathairat
- AIDS Research and Human Retroviruses, Vol. 31, Issue 11
Infant HIV Type 1 gp120 Vaccination Elicits Robust and Durable Anti-V1V2 Immunoglobulin G Responses and Only Rare Envelope-Specific Immunoglobulin A Responses
journal, August 2014
- Fouda, Genevieve G.; Cunningham, Coleen K.; McFarland, Elizabeth J.
- The Journal of Infectious Diseases, Vol. 211, Issue 4
Novel prime-boost vaccine strategies against HIV-1
journal, July 2019
- Excler, Jean-Louis; Kim, Jerome H.
- Expert Review of Vaccines, Vol. 18, Issue 8
Identification of New Regions in HIV-1 gp120 Variable 2 and 3 Loops that Bind to α4β7 Integrin Receptor
journal, December 2015
- Peachman, Kristina K.; Karasavvas, Nicos; Chenine, Agnes-Laurence
- PLOS ONE, Vol. 10, Issue 12
Fowlpoxvirus recombinants coding for the CIITA gene increase the expression of endogenous MHC-II and Fowlpox Gag/Pro and Env SIV transgenes
journal, January 2018
- Bissa, Massimiliano; Forlani, Greta; Zanotto, Carlo
- PLOS ONE, Vol. 13, Issue 1
Immune Focusing and Enhanced Neutralization Induced by HIV-1 gp140 Chemical Cross-Linking
journal, September 2013
- Schiffner, T.; Kong, L.; Duncan, C. J. A.
- Journal of Virology, Vol. 87, Issue 18
Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity
journal, October 2017
- Mayr, Luzia M.; Decoville, Thomas; Schmidt, Sylvie
- Scientific Reports, Vol. 7, Issue 1
Vaccine-Induced IgG Antibodies to V1V2 Regions of Multiple HIV-1 Subtypes Correlate with Decreased Risk of HIV-1 Infection
journal, February 2014
- Zolla-Pazner, Susan; deCamp, Allan; Gilbert, Peter B.
- PLoS ONE, Vol. 9, Issue 2
Epitope Mapping of Conformational V2-specific Anti-HIV Human Monoclonal Antibodies Reveals an Immunodominant Site in V2
journal, July 2013
- Mayr, Luzia M.; Cohen, Sandra; Spurrier, Brett
- PLoS ONE, Vol. 8, Issue 7
Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant
journal, April 2018
- Wen, Yingxia; Trinh, Hung V.; Linton, Christine E.
- PLOS ONE, Vol. 13, Issue 4
Vaccine-induced Human Antibodies Specific for the Third Variable Region of HIV-1 gp120 Impose Immune Pressure on Infecting Viruses
journal, November 2014
- Zolla-Pazner, Susan; Edlefsen, Paul T.; Rolland, Morgane
- EBioMedicine, Vol. 1, Issue 1
Fowlpoxvirus recombinants coding for the CIITA gene increase the expression of endogenous MHC-II and Fowlpox Gag/Pro and Env SIV transgenes
journal, January 2018
- Bissa, Massimiliano; Forlani, Greta; Zanotto, Carlo
- PLOS ONE, Vol. 13, Issue 1
Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial
journal, September 2013
- Gottardo, Raphael; Bailer, Robert T.; Korber, Bette T.
- PLoS ONE, Vol. 8, Issue 9
Revisiting the Correlate of Reduced HIV Infection Risk in the Rv144 Vaccine Trial
journal, September 2019
- Zolla-Pazner, Susan; Gilbert, Peter B.
- Journal of Virology, Vol. 93, Issue 17
Chemokine-adjuvanted electroporated DNA vaccine induces substantial protection from simian immunodeficiency virus vaginal challenge
journal, May 2015
- Kutzler, M. A.; Wise, M. C.; Hutnick, N. A.
- Mucosal Immunology, Vol. 9, Issue 1
Vaccine-induced V1V2-specific antibodies control and or protect against infection with HIV, SIV and SHIV
journal, January 2019
- Zolla-Pazner, Susan; Alvarez, Raymond; Kong, Xiang-Peng
- Current Opinion in HIV and AIDS, Vol. 14, Issue 4
Characterization of HIV-1 gp120 antibody specificities induced in anogenital secretions of RV144 vaccine recipients after late boost immunizations
journal, April 2018
- Akapirat, Siriwat; Karnasuta, Chitraporn; Vasan, Sandhya
- PLOS ONE, Vol. 13, Issue 4
Liposome-Encapsulated Human Immunodeficiency Virus-1 gp120 Induces Potent V1V2-Specific Antibodies in Humans
journal, June 2018
- Rao, Mangala; Onkar, Sayali; Peachman, Kristina K.
- The Journal of Infectious Diseases, Vol. 218, Issue 10
A critical question for HIV vaccine development: Which antibodies to induce?
journal, July 2014
- Zolla-Pazner, S.
- Science, Vol. 345, Issue 6193
Which Antibody Functions are Important for an HIV Vaccine?
journal, June 2014
- Su, Bin; Moog, Christiane
- Frontiers in Immunology, Vol. 5
Achieving Potent Autologous Neutralizing Antibody Responses against Tier 2 HIV-1 Viruses by Strategic Selection of Envelope Immunogens
journal, March 2016
- Hessell, Ann J.; Malherbe, Delphine C.; Pissani, Franco
- The Journal of Immunology, Vol. 196, Issue 7
Control of Heterologous Simian Immunodeficiency Virus SIV smE660 Infection by DNA and Protein Coimmunization Regimens Combined with Different Toll-Like-Receptor-4-Based Adjuvants in Macaques
journal, May 2018
- Singh, Shakti; Ramírez-Salazar, Eric G.; Doueiri, Rami
- Journal of Virology, Vol. 92, Issue 15
Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research
journal, August 2015
- Wieczorek, Lindsay; Krebs, Shelly J.; Kalyanaraman, Vaniambadi
- Journal of Virology, Vol. 89, Issue 15
Chemokine-adjuvanted electroporated DNA vaccine induces substantial protection from simian immunodeficiency virus vaginal challenge
journal, May 2015
- Kutzler, M. A.; Wise, M. C.; Hutnick, N. A.
- Mucosal Immunology, Vol. 9, Issue 1
HIV-1 vaccination by needle-free oral injection induces strong mucosal immunity and protects against SHIV challenge
journal, February 2019
- Jones, Andrew T.; Shen, Xiaoying; Walter, Korey L.
- Nature Communications, Vol. 10, Issue 1
Distinct Mechanisms Regulate Exposure of Neutralizing Epitopes in the V2 and V3 Loops of HIV-1 Envelope
journal, August 2014
- Upadhyay, C.; Mayr, L. M.; Zhang, J.
- Journal of Virology, Vol. 88, Issue 21
Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response
journal, September 2016
- Zolla-Pazner, Susan; Powell, Rebecca; Yahyaei, Sara
- Journal of Virology, Vol. 90, Issue 24
Progress in HIV vaccine development
journal, October 2001
- Johnston, M.
- Current Opinion in Pharmacology, Vol. 1, Issue 5
Adenoviral vectors elicit humoral immunity against variable loop 2 of clade C HIV-1 gp120 via “Antigen Capsid-Incorporation” strategy
journal, January 2016
- Gu, Linlin; Krendelchtchikova, Valentina; Krendelchtchikov, Alexandre
- Virology, Vol. 487
Vaccine-Induced Env V1-V2 IgG3 Correlates with Lower HIV-1 Infection Risk and Declines Soon After Vaccination
journal, March 2014
- Yates, N. L.; Liao, H. -X.; Fong, Y.
- Science Translational Medicine, Vol. 6, Issue 228
Induction of circulating T follicular helper cells and regulatory T cells correlating with HIV-1 gp120 variable loop antibodies by a subtype C prophylactic vaccine tested in a Phase I trial in India
journal, August 2018
- Munusamy Ponnan, Sivasankaran; Swaminathan, Soumya; Tiruvengadam, Kannan
- PLOS ONE, Vol. 13, Issue 8
Cryptic Determinant of α4β7 Binding in the V2 Loop of HIV-1 gp120
journal, September 2014
- Tassaneetrithep, Boonrat; Tivon, Doreen; Swetnam, James
- PLoS ONE, Vol. 9, Issue 9
Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV - New Technologies and their Impact on the HIV Vaccine Field
journal, July 2017
- Wines, Bruce D.; Billings, Hugh; Mclean, Milla R.
- Current HIV Research, Vol. 15, Issue 3
Receptor Binding Domain Based HIV Vaccines
journal, January 2015
- Liu, Huan; Bi, Wenwen; Wang, Qian
- BioMed Research International, Vol. 2015
Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial
journal, September 2013
- Gottardo, Raphael; Bailer, Robert T.; Korber, Bette T.
- PLoS ONE, Vol. 8, Issue 9
Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIV mac251 Acquisition
journal, September 2016
- Gordon, Shari N.; Liyanage, Namal P. M.; Doster, Melvin N.
- The Journal of Immunology, Vol. 197, Issue 7
Impact of Poxvirus Vector Priming, Protein Coadministration, and Vaccine Intervals on HIV gp120 Vaccine-Elicited Antibody Magnitude and Function in Infant Macaques
journal, October 2017
- Phillips, Bonnie; Fouda, Genevieve G.; Eudailey, Josh
- Clinical and Vaccine Immunology, Vol. 24, Issue 10
Recent update in HIV vaccine development
journal, January 2016
- Shin, So Youn
- Clinical and Experimental Vaccine Research, Vol. 5, Issue 1
Impact of amino acid substitutions in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 on viral neutralization susceptibility to broadly neutralizing antibodies specific for the CD4 binding site
journal, January 2014
- Utachee, Piraporn; Isarangkura-na-ayuthaya, Panasda; Tokunaga, Kenzo
- Retrovirology, Vol. 11, Issue 1
Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to α4β7
journal, August 2018
- Lertjuthaporn, Sakaorat; Cicala, Claudia; Van Ryk, Donald
- PLOS Pathogens, Vol. 14, Issue 8
Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates
journal, May 2015
- Shen, Xiaoying; Duffy, Ryan; Howington, Robert
- Journal of Virology, Vol. 89, Issue 16
Peptide Targeted by Human Antibodies Associated with HIV Vaccine-Associated Protection Assumes a Dynamic α-Helical Structure
journal, January 2017
- Aiyegbo, Mohammed S.; Shmelkov, Evgeny; Dominguez, Lorenzo
- PLOS ONE, Vol. 12, Issue 1
Predominant envelope variable loop 2-specific and gp120-specific antibody-dependent cellular cytotoxicity antibody responses in acutely SIV-infected African green monkeys
journal, March 2018
- Nguyen, Quang N.; Martinez, David R.; Himes, Jonathon E.
- Retrovirology, Vol. 15, Issue 1
Modulation of Antibody Responses to the V1V2 and V3 Regions of HIV-1 Envelope by Immune Complex Vaccines
journal, October 2018
- Hioe, Catarina E.; Kumar, Rajnish; Upadhyay, Chitra
- Frontiers in Immunology, Vol. 9
Epitope Mapping of Conformational V2-specific Anti-HIV Human Monoclonal Antibodies Reveals an Immunodominant Site in V2
journal, July 2013
- Mayr, Luzia M.; Cohen, Sandra; Spurrier, Brett
- PLoS ONE, Vol. 8, Issue 7
Human Immunodeficiency Virus C.1086 Envelope gp140 Protein Boosts following DNA/Modified Vaccinia Virus Ankara Vaccination Fail To Enhance Heterologous Anti-V1V2 Antibody Response and Protection against Clade C Simian-Human Immunodeficiency Virus Challenge
journal, October 2019
- Styles, Tiffany M.; Gangadhara, Sailaja; Reddy, Pradeep B. J.
- Journal of Virology, Vol. 93, Issue 20
HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees
journal, January 2018
- Yates, Nicole L.; deCamp, Allan C.; Korber, Bette T.
- Journal of Virology, Vol. 92, Issue 8
Predominant envelope variable loop 2-specific and gp120-specific antibody-dependent cellular cytotoxicity antibody responses in acutely SIV-infected African green monkeys
journal, March 2018
- Nguyen, Quang N.; Martinez, David R.; Himes, Jonathon E.
- Retrovirology, Vol. 15, Issue 1
Structure/Function Studies Involving the V3 Region of the HIV-1 Envelope Delineate Multiple Factors That Affect Neutralization Sensitivity
journal, October 2015
- Zolla-Pazner, Susan; Cohen, Sandra Sharpe; Boyd, David
- Journal of Virology, Vol. 90, Issue 2
Envelope Variants Circulating as Initial Neutralization Breadth Developed in Two HIV-Infected Subjects Stimulate Multiclade Neutralizing Antibodies in Rabbits
journal, September 2014
- Malherbe, D. C.; Pissani, F.; Sather, D. N.
- Journal of Virology, Vol. 88, Issue 22
Impact of Poxvirus Vector Priming, Protein Coadministration, and Vaccine Intervals on HIV gp120 Vaccine-Elicited Antibody Magnitude and Function in Infant Macaques
text, January 2017
- Camden, Bay,; G., Fouda, Genevieve; Josh, Eudailey,
- The University of North Carolina at Chapel Hill University Libraries
Progress in HIV vaccine development
journal, January 2017
- Hsu, Denise C.; O'Connell, Robert J.
- Human Vaccines & Immunotherapeutics, Vol. 13, Issue 5